Neumora Therapeutics Inc — Quarterly Cash Flow (NASDAQ:NMRA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 352.54 M316.97 M256.75 M223.82 M177.83 M Total liabilities 31.8 M29.91 M28.38 M40.95 M45.67 M Total equity 320.74 M287.06 M228.36 M182.88 M132.16 M Total liabilities & shareholders' equities 352.54 M316.97 M256.75 M223.82 M177.83 M Total debt ————— Net debt —————

Haberler

Le directeur financier de Neumora Therapeutics, Milligan, vend pour 5.119$ d’actions

Neumora Therapeutics CFO Milligan sells $5119 in shares

Neumora Therapeutics, Inc. (NMRA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Slideshow (NASDAQ:NMRA) 2026-02-12

Intel, Wells Fargo among market cap stock movers on Tuesday

Oracle, Palantir among market cap stock movers on Monday

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio

Leerink Partners initie la couverture de l’action Neumora avec une note Surperformance

Leerink Partners initiates coverage on Neumora stock with Outperform rating

Mizuho maintient sa recommandation "Surperformance" sur l’action Neumora Therapeutics

Mizuho reiterates Outperform rating on Neumora Therapeutics stock

Eli Lilly and Regencell among market cap stock movers on Wednesday

Eli Lilly and Intel lead market cap stock movers on Wednesday